FREDA SIGMON: Open Payments
NPI 1376935379 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $125 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Forte Bio-Pharma LLC | 2 | $42 |
| Ipsen Biopharmaceuticals, Inc | 1 | $29 |
| ABBVIE INC. | 1 | $22 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
Products named: JOURNAVX, RELISTOR, Belbuca, PROLATE, Dysport, BOTOX, Xeomin.
Industry payments across NC — which companies pay providers there.
